Author:
Zhang Zhuo,Wu Hongshi,Gong Xun,Yan Yuerong,Li Xiaohui,Yang Rongxue,Wu Muchao,Xu Mingtong
Abstract
AbstractThe primary objective of this study is to understand the regulatory role of epigenetics in thyroid-associated ophthalmopathy (TAO) using multi-omics sequencing data. We utilized tRFs sequencing data, DNA methylation sequencing data, and lncRNA/circRNA/mRNA sequencing data, as well as several RNA methylation target prediction websites, to analyze the regulatory effect of DNA methylation, non-coding RNA, and RNA methylation on TAO-associated genes. Through differential expression analysis, we identified 1019 differentially expressed genes, 985 differentially methylated genes, and 2601 non-coding RNA. Functional analysis showed that differentially expressed genes were mostly associated with the PI3K signaling pathway and the IL17 signaling pathway. Genes regulated by DNA epigenetic regulatory networks were mainly related to the Cytokine-cytokine receptor interaction pathway, whereas genes regulated by RNA epigenetic regulatory networks were primarily related to the T cell receptor signaling pathway. Finally, our integrated regulatory network analysis revealed that epigenetics mainly impacts the occurrence of TAO through its effects on key pathways such as cell killing, cytokine production, and immune response. In summary, this study is the first to reveal a new mechanism underlying the development of TAO and provides new directions for future TAO research.
Funder
Sun Yat-sen University Clinical Research 5010 Program
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Kulis, M. & Esteller, M. DNA methylation and cancer. Adv. Genet. 70, 27–56 (2010).
2. Nie, J. H., Li, T. X., Zhang, X. Q. & Liu, J. Roles of non-coding RNAs in normal human brain development, brain tumor, and neuropsychiatric disorders. Noncoding RNA 5(2), 36 (2019).
3. Ghafouri-Fard, S., Harsij, A., Hussen, B. M., Taheri, M. & Ayatollahi, S. A. A review on the role of SNHG8 in human disorders. Pathol. Res. Pract. 245, 154458 (2023).
4. Doghish, A. S. et al. miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses. Pathol. Res. Pract. 245, 154440 (2023).
5. Taipaleenmaki, H. Secreted microRNAs in bone metastasis. J. Bone Miner. Metab. 41, 358 (2023).